The FDA Steps Up Pressure on Sponsors to Increase Diversity in Clinical Trials — How Decentralized Clinical Trials Can Help
The FDA has been advocating for increased diversity in clinical trials for decades, yet certain groups remain woefully underrepresented in many studies. But it appears we are at a turning point where talk about increasing diversity and inclusiveness is turning into action, and real change is afoot. This paper explores the reasons behind the shift and how decentralized clinical trial methods can enable sponsors and CROs to recruit and retain more diverse participants.
PCM Trials, an independent company headquartered in Denver, Colorado with European operations based out of the UK, brings clinical research to patients wherever and whenever it is most convenient for them. PCM Trials directly recruits, trains, certifies, and manages Certified Mobile Research Nurses (CMRNs) to ensure that each visit meets the highest standards for data quality and patient experience. For more information, visit pcmtrials.com.